Literature DB >> 34993064

The quantitative evaluation of contrast-enhanced ultrasound in the differentiation of small renal cell carcinoma subtypes and angiomyolipoma.

Hui Liu1,2, Hongli Cao1,2, Lin Chen1,2, Liang Fang1,2, Yingchun Liu1,2, Jia Zhan1,2, Xuehong Diao1,2, Yue Chen1,2.   

Abstract

BACKGROUND: Contrast-enhanced ultrasound (CEUS) has been widely used for renal lesion diagnosis and differential diagnosis. However, qualitative analysis of CEUS is subject to examinations with low reproducibility. This study aims to investigate the diagnostic value of CEUS quantitative parameters in differentiating small renal cell carcinoma (RCC) subtypes and angiomyolipoma (AML).
METHODS: A retrospective analysis was performed on 97 cases of a small renal mass undergoing a CEUS before a radical or partial nephrectomy procedure. A region of interest (ROI) was placed in the tumor's maximum enhanced region (ROImax) as much as possible, and adjacent renal cortex (ROIrefer) was selected from normal renal tissue around a mass of the same depth. The time-intensity curve (TIC) was used to analyze the ROImax and the ROIrefer of the tumors quantitatively. Then the parameters of the ROImax and the ROIrefer, including the differences between the parameters of the ROImax and the ROIrefer, were analyzed statistically.
RESULTS: In RCC and clear cell renal cell carcinoma (ccRCC), the peak intensity (PI), slope (SL), area under the curve (AUC), area under the wash-in curve (AWI), area under the wash-out curve (AWO), time to peak intensity (TTP) and the mean transit time (MTT) were statistically significant between ROImax and ROIrefer (all P=0.000). The △PI (△PI = PImax - PIrefer), △SL (△SL = SLmax - SLrefer), △AUC (△AUC = AUCmax - AUCrefer), △AWI (△AWI = AWImax - AWIrefer) and △AWO (△AWO = AWOmax - AWOrefer) of RCC were significantly higher than in AML (P=0.007, 0.000, 0.003, 0.048, 0.009, respectively), while the TTP (△TTP = TTPmax - TTPrefer) and △MTT (△MTT = MTTmax - MTTrefer) of RCC were significantly lower (both P=0.000). In comparison with papillary renal cell carcinoma (pRCC) and chromophobe renal cell carcinoma (chRCC), the △PI, △SL, △AUC and △AWO of ccRCC were all larger (all P<0.05). The sensitivity, specificity, and AUC of the combination of parameter difference for differentiating RCC from AML were 100%, 81.2%, and 0.965, respectively, and for differentiating ccRCC from pRCC and chRCC, 85.71%, 85.92% and 0.911, respectively.
CONCLUSIONS: CEUS quantitative parameters have value in differentiating small RCC from AML and distinguishing ccRCC from pRCC and chRCC. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Renal cell carcinoma (RCC); angiomyolipoma (AML); contrast-enhanced ultrasound (CEUS); quantitative analysis

Year:  2022        PMID: 34993064      PMCID: PMC8666748          DOI: 10.21037/qims-21-248

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  32 in total

1.  Contrast-enhanced ultrasound using a time-intensity curve for the diagnosis of renal cell carcinoma.

Authors:  Shigeyuki Aoki; Ryohei Hattori; Tokunori Yamamoto; Yasuhito Funahashi; Yoshihisa Matsukawa; Momokazu Gotoh; Yoshiaki Yamada; Nobuaki Honda
Journal:  BJU Int       Date:  2010-11-02       Impact factor: 5.588

2.  Renal Masses: Evaluation with Contrast-Enhanced Ultrasound, with a Special Focus on the Pseudocapsule Sign.

Authors:  Wen-Bin Dai; Bo Yu; Xue-Hong Diao; Hongli Cao; Lin Chen; Yue Chen; Jia Zhan
Journal:  Ultrasound Med Biol       Date:  2019-05-21       Impact factor: 2.998

3.  Reproducibility of quantitative assessment of altered hepatic hemodynamics with dynamic contrast-enhanced ultrasound.

Authors:  Thomas P Gauthier; Aun Muhammad; Harpreet S Wasan; Paul D Abel; Edward L S Leen
Journal:  J Ultrasound Med       Date:  2012-09       Impact factor: 2.153

Review 4.  CT and MRI of small renal masses.

Authors:  Zhen J Wang; Antonio C Westphalen; Ronald J Zagoria
Journal:  Br J Radiol       Date:  2018-05-10       Impact factor: 3.039

5.  Contrast-enhanced ultrasound for differentiating benign from malignant solid small renal masses: comparison with contrast-enhanced CT.

Authors:  Shu-Ping Wei; Chao-Li Xu; Qing Zhang; Qi-Rui Zhang; Yan-E Zhao; Peng-Fei Huang; Ying-Dong Xie; Chang-Sheng Zhou; Fu-Li Tian; Bin Yang
Journal:  Abdom Radiol (NY)       Date:  2017-08

Review 6.  Applications of contrast-enhanced ultrasound in the kidney.

Authors:  Brittany Kazmierski; Corinne Deurdulian; Hisham Tchelepi; Edward G Grant
Journal:  Abdom Radiol (NY)       Date:  2018-04

7.  Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size.

Authors:  Sandra Steffens; Frederik C Roos; Martin Janssen; Frank Becker; Julie Steinestel; Mahmoud Abbas; Konrad Steinestel; Gerd Wegener; Stefan Siemer; Joachim W Thüroff; Rainer Hofmann; Michael Stöckle; Mark Schrader; Arndt Hartmann; Kerstin Junker; Markus A Kuczyk; Andres J Schrader
Journal:  Virchows Arch       Date:  2014-09-02       Impact factor: 4.064

8.  Contrast-enhanced ultrasound (CEUS) reliably rules out neoplasm in developmental renal pseudotumor.

Authors:  Paul Spiesecke; Thomas Fischer; Andreas Maxeiner; Bernd Hamm; Markus H Lerchbaumer
Journal:  Acta Radiol       Date:  2020-07-06       Impact factor: 1.990

9.  Cost-effectiveness analysis of multiple imaging modalities in diagnosis and follow-up of intermediate complex cystic renal lesions.

Authors:  Paul Spiesecke; Thomas Reinhold; Yano Wehrenberg; Sven Werner; Andreas Maxeiner; Jonas Busch; Thomas Fischer; Bernd Hamm; Markus Herbert Lerchbaumer
Journal:  BJU Int       Date:  2021-03-18       Impact factor: 5.588

10.  Contrast-Enhanced Ultrasonography with Quantitative Analysis allows Differentiation of Renal Tumor Histotypes.

Authors:  Di Sun; Cong Wei; Yi Li; Qijie Lu; Wei Zhang; Bing Hu
Journal:  Sci Rep       Date:  2016-10-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.